Two expert pharmacists discuss key issues regarding the use of BTK inhibitors in patients with CLL.

Earn Credit / Learning Objectives & Disclosures

---

Full URLs:
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/924742?src=mkm_podcast_addon_924742